229 related articles for article (PubMed ID: 24380737)
1. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
[TBL] [Abstract][Full Text] [Related]
2. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
3. Training the next generation of providers in addiction medicine.
Rasyidi E; Wilkins JN; Danovitch I
Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
[TBL] [Abstract][Full Text] [Related]
4. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
5. Treatment of GHB withdrawal syndrome: Catch 22 or challenge for addiction medicine?
de Jong CA; Kamal R; van Noorden M; Broers B
Addiction; 2013 Sep; 108(9):1686. PubMed ID: 23718746
[No Abstract] [Full Text] [Related]
6. [Detoxification of patients with GHB dependence].
de Weert-van Oene GH; Schellekens AF; Dijkstra BA; Kamal R; de Jong CA
Tijdschr Psychiatr; 2013; 55(11):885-90. PubMed ID: 24242149
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.
Brunt TM; Koeter MW; Hertoghs N; van Noorden MS; van den Brink W
Drug Alcohol Depend; 2013 Aug; 131(3):316-9. PubMed ID: 23332440
[TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyrate detoxification by titration and tapering.
de Jong CA; Kamal R; Dijkstra BA; de Haan HA
Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
[TBL] [Abstract][Full Text] [Related]
9. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
Beurmanjer H; Luykx JJ; De Wilde B; van Rompaey K; Buwalda VJA; De Jong CAJ; Dijkstra BAG; Schellekens AFA
CNS Drugs; 2020 Jun; 34(6):651-659. PubMed ID: 32319006
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
[TBL] [Abstract][Full Text] [Related]
11. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
12. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
Caputo F; Francini S; Stoppo M; Lorenzini F; Vignoli T; Del Re A; Comaschi C; Leggio L; Addolorato G; Zoli G; Bernardi M
J Psychopharmacol; 2009 Nov; 23(8):883-90. PubMed ID: 18635689
[TBL] [Abstract][Full Text] [Related]
13. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
15. [Course and complications of GHB detoxification treatment: a 1-year case series].
Neu P
Nervenarzt; 2019 May; 90(5):509-515. PubMed ID: 30362026
[TBL] [Abstract][Full Text] [Related]
16. A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.
Beurmanjer H; Asperslag EM; Oliemeulen L; Goudriaan AE; De Jong CAJ; Schellekens ASA; Dijkstra BAG
Eur Addict Res; 2019; 25(5):248-255. PubMed ID: 31163444
[TBL] [Abstract][Full Text] [Related]
17. Recent trends in adolescent substance use, primary care screening, and updates in treatment options.
Fournier ME; Levy S
Curr Opin Pediatr; 2006 Aug; 18(4):352-8. PubMed ID: 16914986
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
19. GHB, GBL and 1,4-BD addiction.
Brunt TM; van Amsterdam JG; van den Brink W
Curr Pharm Des; 2014; 20(25):4076-85. PubMed ID: 24001290
[TBL] [Abstract][Full Text] [Related]
20. Comorbid internet addiction in male clients of inpatient addiction rehabilitation centers: psychiatric symptoms and mental comorbidity.
Wölfling K; Beutel ME; Koch A; Dickenhorst U; Müller KW
J Nerv Ment Dis; 2013 Nov; 201(11):934-40. PubMed ID: 24177479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
